M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC

Published:2016-07-28 Issue:3 Volume:19 Page:326-331
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Chu T.,Jiang L.,Ying W.,Han B.

Funder

Chinese National Science Foundation

Western Medicine Guide Project of Shanghai Committee of Science and Technology

Science and Technology Development Fund of Shanghai Chest Hospital

Shanghai Jiao Tong University Grant for Interdisciplinary Research on Medicine and Engineering

Fund of Vascular Targeted therapy in Oncology of CSCO

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-016-1533-x.pdf

Reference18 articles.

1. Caramori G, Casolari P, Cavallesco GN, Giuffre S, Adcock I, Papi A. Mechanisms involved in lung cancer development in COPD. Int J Biochem Cell Biol. 2011;43(7):1030–44. doi: 10.1016/j.biocel.2010.08.022 .

2. Buttery RC, Rintoul RC, Sethi T. Small cell lung cancer: the importance of the extracellular matrix. Int J Biochem Cell Biol. 2004;36(7):1154–60. doi: 10.1016/S1357-2725(03)00261-9 .

3. Pei J, Lou Y, Zhong R, Han B. MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer. Tumour Biol. 2014;35(7):6673–8. doi: 10.1007/s13277-014-1850-z .

4. Weaver BA. How taxol/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25(18):2677–81. doi: 10.1091/mbc.E14-04-0916 .

5. Meng J, Guo F, Xu H, Liang W, Wang C, Yang XD. Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Sci Rep. 2016;6:22390. doi: 10.1038/srep22390 .

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic biomarkers in lung cancer patients in terms of long-term survival;Turkish Journal of Internal Medicine;2021-03-04

2. Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells;Molecular Medicine Reports;2020-07-20

3. Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives;Frontiers in Pharmacology;2020-01-30

4. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients—a single‐center retrospective cohort study;Transplant International;2019-05-15

5. Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities;Therapeutic Drug Monitoring;2019-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3